Scancell
Susan is an experienced life science financier with over 25 years of capital markets and investment banking experience, including Managing Director of Equity Capital Markets at Citigroup Global Markets Limited and most recently until 2018, Managing Director at Torreya Partners LLC, a global investment banking firm serving companies in the Life Sciences industry. Susan is currently a Non-Executive Director and Chairman of the Audit Committee of Evgen Pharma Plc, an AIM-listed clinical-stage drug development company.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Scancell
Scancell's mission is to overcome this breach in defenses by developing products that stimulate the immune system to treat or prevent cancer.